Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-019565

EVP, Growth Markets Commercial sold 461 shares at $19.50 ($8,989)

  • EVP, Growth Markets Commercial acquired 880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nazzi Gianfranco · EVP, Growth Markets Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-12 Exercise or conversion : show line 1 in the form +880 5,792.36 D
2018-03-12 Sale : show line 2 in the form −461 $19.50 $8,989 5,331.36 D
Open-market sales · 461 sh · avg $19.50 · $8,989

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-12 Exercise or conversion : show line 3 in the form Restricted Share Units −880 883 D
Loading xslF345X03/doc4.xml…